Suppr超能文献

益生菌对妊娠期糖尿病妊娠结局的影响:系统评价与荟萃分析

Effect of probiotics on pregnancy outcomes in gestational diabetes: systematic review and meta-analysis.

作者信息

Wu Rui, Luan Jiasi, Hu Juanjuan, Li Zuojing

机构信息

School of Life Sciences and Biopharmaceuticals, Shenyang Pharmaceutical University, Shenyang, China.

School of Medical Devices, Shenyang Pharmaceutical University, Shenyang, China.

出版信息

Arch Gynecol Obstet. 2024 Aug;310(2):769-781. doi: 10.1007/s00404-023-07346-5. Epub 2024 Jan 18.

Abstract

OBJECTIVE

Gestational diabetes mellitus (GDM) is a prevalent complication during pregnancy associated with numerous adverse outcomes. There is emerging evidence suggesting the potential of probiotics as a therapeutic measure for GDM; however, existing studies have yielded contradictory results. This meta-analysis assessed the efficacy of probiotics on blood glucose management and pregnancy outcomes in patients with GDM.

METHODS

A comprehensive search of the PubMed, Embase, and Cochrane databases was conducted up to August 22, 2023, to identify relevant studies. The primary outcomes focused on fasting blood glucose (FBG), fasting serum insulin (FSI), homeostasis model assessment of insulin resistance (HOMA-IR), and quantitative insulin sensitivity check index (QUICKI). The secondary outcomes included various maternal and neonatal outcomes.

RESULTS

This meta-analysis included 15 randomized controlled trials (RCTs), encompassing 1006 patients with GDM. The results showed that, compared to a placebo, probiotics demonstrated a significant reduction in FBG (MD - 2.58, 95% CI - 4.38 to - 0.79, p < 0.01), FSI (MD - 2.29, 95% CI - 3.40 to - 1.18, p < 0.01), HOMA-IR (MD - 0.56, 95% CI - 0.81 to - 0.32, p < 0.01), and birth weight (MD - 101.20, 95% CI - 184.62 to - 17.77, p = 0.02). Furthermore, it resulted in fewer neonatal intensive care unit (NICU) admissions (RR 0.60, 95% CI 0.40-0.89, p = 0.01), instances of hyperbilirubinemia (RR 0.31, 95% CI 0.16-0.61, p < 0.01), and elevated QUICKI (MD 0.01, 95% CI 0.00-0.01, p < 0.01). No significant impact was observed in the other analyzed outcomes.

CONCLUSIONS

In conclusion, probiotics improve FBG, FSI, and HOMA-IR, and reduce the occurrence of neonatal hyperbilirubinemia, NICU admissions, and birth weight in the offspring of patients with GDM. However, the quality of the evidence, as per the GRADE approach, varies from high to low, necessitating further studies to consolidate these findings.

摘要

目的

妊娠期糖尿病(GDM)是孕期常见的并发症,与众多不良结局相关。越来越多的证据表明益生菌有可能作为GDM的一种治疗措施;然而,现有研究结果相互矛盾。本荟萃分析评估了益生菌对GDM患者血糖管理和妊娠结局的疗效。

方法

截至2023年8月22日,对PubMed、Embase和Cochrane数据库进行全面检索,以识别相关研究。主要结局集中在空腹血糖(FBG)、空腹血清胰岛素(FSI)、胰岛素抵抗稳态模型评估(HOMA-IR)和定量胰岛素敏感性检查指数(QUICKI)。次要结局包括各种母婴结局。

结果

本荟萃分析纳入了15项随机对照试验(RCT),涵盖1006例GDM患者。结果显示,与安慰剂相比,益生菌使FBG(MD - 2.58,95%CI - 4.38至 - 0.79,p < 0.01)、FSI(MD - 2.29,95%CI - 3.40至 - 1.18,p < 0.01)、HOMA-IR(MD - 0.56,95%CI - 0.81至 - 0.32,p < 0.01)和出生体重(MD - 101.20,95%CI - 184.62至 - 17.77,p = 0.02)显著降低。此外,它还减少了新生儿重症监护病房(NICU)入院率(RR 0.60,95%CI 0.40 - 0.89,p = 0.01)、高胆红素血症发生率(RR 0.31,95%CI 0.16 - 0.61,p < 0.01),并提高了QUICKI(MD 0.01,95%CI 0.00 - 0.01,p < 0.01)。在其他分析的结局中未观察到显著影响。

结论

总之,益生菌可改善GDM患者的FBG、FSI和HOMA-IR,并降低其后代新生儿高胆红素血症的发生率、NICU入院率和出生体重。然而,根据GRADE方法,证据质量从高到低不等,需要进一步研究来巩固这些发现。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验